Clinical Trial

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Study acronym: PREDICT
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this PREDICT is to assess a personalize approach to screening and management of cervical cancer testing. The investigators will evaluate patients who are due for a follow up cervical cancer screening in the primary care clinics in the Massachusetts General Brigham system. Patients will be randomized by clinic into three different arms (Arm 1: standard care, Arm 2: visit based reminders, Arm 3: visit based reminders and population health outreach)
Protocol Amendment History 5 changes
critical Recruitment opened 2026-08-08
notable Primary completion pushed: 2028-06-15 -> 2028-07-22 2026-08-08
minor Completion pushed: 2028-12-15 -> 2029-01-22 2026-08-08
notable Primary completion pushed: 2028-04-15 -> 2028-06-15 2026-05-27
minor Completion moved earlier: 2029-02-15 -> 2028-12-15 2026-03-27
Trial Details
NCT Number NCT06872346
Lead Sponsor Massachusetts General Hospital
Conditions Cervical Cancer Screening
Enrollment 7,500 participants
Start Date 2026-07-22
Primary Completion 2028-07-22 (estimated)
Study Completion 2029-01-22 (estimated)
Updated on ClinicalTrials.gov 2026-08-07